Brief: Bone Therapeutics Treats First Patient In ALLOB IIb Tibial Fracture Study
Jan 12 (Reuters) - BONE THERAPEUTICS SA BOTHE.BR :
* BONE THERAPEUTICS TREATS FIRST PATIENT IN ALLOB PHASE IIB
TIBIAL
FRACTURE STUDY
* TOPLINE RESULTS ANTICIPATED IN H2 2022
* ALL PATIENTS EXPECTED TO BE RECRUITED IN H1 2022
Source text for Eikon: ID:nGNE4YM79C
Further company coverage: BOTHE.BR
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Biosenic SA
See all newsBrief: Biosenic Says Enterprise Court Of Nivelles Approves Co's Restructuring Plan
Brief: Biosenic Anticipates Having Sufficient Cash To Carry Out Its Business Objectives Until Q3 2024
Brief: BioSenic Patent Granted In Canada For Broader Protection Of ATO Therapeutic Platform
Brief: Biosenic Files For Additional Patent Protection For Osteoarthritis Drug
Brief: BioSenic Signs New Binding Term Sheet With Phebra PTY Ltd